← Open Payments lookup

DAWN DOLAN: Open Payments

NPI 1871549048 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$950 in 49 payments from 15 companies in 2025. Trend: 2023 $990 · 2024 $566 · 2025 $950

Food & beverage: $950
CompanyPaymentsAmount
Novo Nordisk Inc4$159
Exact Sciences Corporation9$146
Lilly USA, LLC13$136
Takeda Pharmaceuticals U.S.A., Inc.6$121
Teva Pharmaceuticals USA, Inc.1$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$60
PFIZER INC.3$48
Regeneron Healthcare Solutions, Inc.2$42
Seqirus USA Inc2$33
E.R. Squibb & Sons, L.L.C.1$17

Products named: Ozempic, ENTYVIO, The Cologuard Plus Collection Kit, MOUNJARO, XIFAXAN, JARDIANCE, Cologuard Collection Kit, DUPIXENT.

Industry payments across NY — which companies pay providers there.